This inventor holds 1 USPTO granted patent. Top assignee: Synthelabo. Active years: 1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985
Title: Jean-Michel Bernardon: Innovator in Therapeutic Compounds
Introduction
Jean-Michel Bernardon is a notable inventor based in Chilly Mazarin, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of new therapeutic compounds. His work focuses on creating innovative solutions that address various health issues.
Latest Patents
Jean-Michel Bernardon holds a patent for "Therapeutically useful imidazo[1,2-a]pyridine derivatives." This patent describes a novel imidazo[1,2-a]pyridine derivative that possesses anxiolytic, antianoxic, sleep-inducing, hypnotic, and anticonvulsant properties. The compounds outlined in his patent are characterized by specific structural formulas that include various functional groups, making them valuable in therapeutic applications.
Career Highlights
Throughout his career, Bernardon has been associated with Synthelabo, a company known for its focus on pharmaceutical innovations. His work has contributed to advancements in the development of therapeutic agents that improve patient outcomes.
Collaborations
Jean-Michel Bernardon has collaborated with notable colleagues such as Jean-Pierre Kaplan and Pascal George. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical field.
Conclusion
Jean-Michel Bernardon's contributions to medicinal chemistry and his innovative patent for therapeutic compounds highlight his role as a significant inventor in the industry. His work continues to influence the development of new treatments that enhance health and well-being.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile